Drugs / FLUAD® influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02560909 | Oct 2015 → Feb 2016 | disease related to transplantation | University Health Network, Toronto | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUAD influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02560909 ↗ |
| Modality | Vaccine | “MF59 adjuvanted intramuscular vaccine” NCT02560909 ↗ |
| Route | Intramuscular | “will be injected in a standard dose (0.5 mL) in the deltoid muscle by trained personnel” NCT02560909 ↗ |